As of 4:00pm ET
| -0.04 / -1.89%|
The 3 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 19.00 and a low estimate of 14.00. The median estimate represents a +717.31% increase from the last price of 2.08.
The current consensus among 6 polled investment analysts is to Buy stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.